<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p style="text-align:justify;"><span >Arrhythmias are disorders of cardiac rate, rhythm and conduction. They can be classified as bradyarrhythmias (heart rate &lt; 60 per minute) and tachyarrhythmias (heart rate &gt; 100 per minute).</span></p><p style="text-align:justify;"><span >Bradyarrhythmias include sinus bradycardia, sinus pauses and atrioventricular blocks. The tachyarrhythmias can further be classified into supraventricular and ventricular arrhythmias, based on their site   of origin. Tachyarrhythmias include atrial fibrillation, atrial flutter, paroxysmal supraventricular tachycardia, ventricular tachycardia and ventricular fibrillation.</span></p><p style="text-align:justify;"> </p><p style="text-align:justify;"><span >Prior to drug treatment of a suspected cardiac arrhythmia, a 12-lead ECG must be done to confirm the rhythm abnormality. It is dangerous  to use an antiarrhythmic drug without doing an ECG. Refer symptomatic patients to hospital immediately. The choice of drug treatment depends on the type of arrhythmia and severity of symptoms.</span></p><h3>CAUSES</h3><p> • Rheumatic heart disease</p><p> • Other valvular heart diseases</p><p> • Hypertensive heart disease</p><p> • Ischaemic heart disease</p><p> • Thyrotoxicosis</p><p> • Hypothyroidism</p><p> • Cardiomyopathies</p><p> • Complete heart block</p><p> • Electrolyte abnormalities particularly hypokalaemia</p><p> • Pericardial disease</p><p> • Drugs</p><p> • Smoking, alcohol, coffee, tea, etc.</p><p> • Pulmonary embolism</p><p> • Post cardiac surgery</p><p> • Idiopathic</p><h3>SYMPTOMS</h3><p> • Palpitations</p><p> • Dizziness</p><p> • Chest discomfort/pain</p><p> • Fatigue</p><p> • Difficulty in breathing</p><p> • Sudden collapse</p><p> • Sudden death</p><h3>SIGNS</h3><p> • Pulse</p><p>• Rate may be fast, slow or normal</p><p>• Rhythm</p><p>•  Pulse deficit (apical rate faster than radial pulse rate; seen in fast atrial fibrillation or flutter)</p><p>•  Hypotension or blood pressure may be unrecordable</p><p>•  Signs of heart failure (may be present)</p><p style="text-align:justify;"> </p><h3>INVESTIGATIONS</h3><ul><li>12-lead ECG</li><li>Serum electrolytes (including magnesium, calcium)</li><li>Thyroid function tests</li><li>Chest X-ray</li><li>Ambulatory ECG (Holter)</li><li>Echocardiography</li></ul><h3>TREATMENT</h3><p><strong>Treatment objectives</strong></p><ul><li>To control ventricular rate</li><li>To restore sinus rhythm</li><li>To relieve symptoms</li><li>To improve functional capacity and quality of life</li><li>To prevent or treat associated complications</li><li>To treat the underlying condition e.g. thyrotoxicosis</li><li>To prevent stroke or systemic thromboembolism</li><li>To reduce morbidity and mortality</li></ul><h3>Non-pharmacological treatment</h3><ul><li>Reassure the patient</li><li>Avoid excessive intake of alcohol, coffee or tea and stop smoking (if these are possible precipitating factors)</li><li>Massage of the carotid sinus on one side for a few seconds. This may terminate an attack of paroxysmal supraventricular tachycardia</li><li>Electrical cardioversion</li></ul><h3>Pharmacological treatment</h3><p><span ><strong>A. Fast atrial fibrillation or atrial flutter-for rate control</strong></span></p><p><span ><strong>1<sup>st</sup> Line Treatment</strong></span></p><p><span ><strong> Evidence Rating: [A]</strong></span></p><ul><li>Atenolol, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>50-100 mg daily</p><p><strong><u>Children</u></strong></p><p>12-18 years;   25-50 mg daily</p><p>1 month-12 years;  12.5-50 mg daily</p><p><strong><u>Neonates</u></strong></p><p>Refer to a paediatrician</p><h3>Or</h3><ul><li>Bisoprolol, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>2.5-10 mg daily</p><p><strong><u>Children</u></strong></p><p>Safety not established in children</p><h3>Or</h3><ul><li>Metoprolol tartrate, oral</li></ul><p><strong><u>Adults</u></strong></p><p>50-100 mg 8 or 12 hourly daily (max. 300 mg daily)</p><p><strong><u>Children</u></strong></p><p>12-18 years; 50 mg 8 or 12 hourly daily (max. 300 mg daily)<br>&lt; 12 years;  refer to a paediatrician</p><p><strong>Or</strong></p><ul><li>Verapamil, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>40-120 mg 6-8 hourly (max. 480 mg daily)</p><p><strong><u>Children</u></strong><br>Refer to a paediatrician</p><p><span >2<sup>nd</sup> Line Treatment Evidence Rating: [A]</span></p><ul><li>Digoxin, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>125-250 micrograms daily</p><p><strong><u>Children</u></strong></p><p>Refer to a paediatrician</p><p><span ><strong>B. Fast atrial fibrillation or atrial flutter-for rhythm control</strong></span></p><p><span >This is required to restore sinus rhythm.</span></p><p><span >Refer to a cardiologist, physician specialist or paediatrician as appropriate.</span></p><h3><span >C. Paroxysmal supraventricular tachycardia</span></h3><p><span ><strong>1<sup>st</sup> Line Treatment</strong></span></p><p><span ><strong> Evidence Rating: [A]</strong></span></p><ul><li>Atenolol, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>50-100 mg daily</p><p><strong><u>Children</u></strong></p><p>12-18 years;   25-50 mg daily</p><p>1 month-12 years;  12.5-50 mg daily</p><p><strong><u>Neonates</u></strong></p><p>Refer to a paediatrician</p><h3>Or</h3><p> • Bisoprolol, oral,</p><p><strong><u>Adults</u></strong></p><p>2.5-10 mg daily</p><p><strong><u>Children</u></strong></p><p>Safety not established in children</p><h3>Or</h3><p> • Metoprolol tartrate, oral,</p><p><strong><u>Adults</u></strong></p><p>50-100 mg 8 or 12 hourly daily (max. 300 mg daily)</p><p><strong><u>Children</u></strong></p><p>12-18 years; 50 mg 8 or 12 hourly daily (max. 300 mg daily)<br>&lt;12 years;  refer to a paediatrician</p><h3>Or</h3><p> • Verapamil, oral,</p><p><strong><u>Adults</u></strong></p><p>40-120 mg 6-8 hourly (max. 480 mg daily)</p><p><strong><u>Children</u></strong><br>Refer to a paediatrician</p><p><span ><strong>2<sup>nd</sup> Line Treatment </strong></span></p><p><span ><strong>Evidence Rating: [A]</strong></span></p><p> • Digoxin, oral,</p><p><strong><u>Adults</u></strong></p><p>125-250 micrograms daily</p><p><strong><u>Children</u></strong></p><p>Refer to a paediatrician</p><h3><span >D.   Prevention of stroke or systemic thromboembolism in atrial <strong>fibrillation or flutter</strong></span></h3><p><span >Patients should be given long-term anticoagulation.</span></p><p><span >(See options for long-term anticoagulation in section on 'DVT' or 'Pulmonary Embolism').</span></p><h3>REFERRAL CRITERIA</h3><p style="text-align:justify;"><span >Refer all patients to a cardiologist, physician specialist or paediatrician for further evaluation and management after the initial treatment immediately.</span></p><p><span >All symptomatic patients, as well as those who cannot have an ECG done or interpreted, or who present with heart failure, should be referred </span></p>
    <p><strong> FLOWCHART</strong></p>
    <div style="width: 95vw;">
    <img src="https://osamfrimpong.github.io/stg_app_web/images/arrhythmias.png" alt="Flowchart: Arrhythmias" style="max-width: 100%;height: auto;margin: auto;">
    </div>
    <p><br /><strong>Fig 7-9: Flowchart: Arrhythmias</strong></p>
</body>
</html>
